We demonstrated that IL-39 could play a pathogenic immune role by increasing the proportion of Th2 cells and secretion of TNF-α in CD4+ and CD8+T cells in scleroderma-like and lupus-like cGVHD models. This evidence concerns the gene CD4 and scleroderma.